The story of Viagra presents a nuanced case for investors in the drug sector. While initially a tremendous success, creating billions, the patent lapse and the subsequent flood of generic competitors have drastically https://pharma471113.thenerdsblog.com/47884450/the-little-copyright-and-pharma-a-hazardous-play